Prophylactic Cranial Irradiation Uses Side Effects Procedure Results
Since 2007, PCI had been widely accepted as the standard of care for people with small cell lung cancer (SCLC), an uncommon and aggressive form of lung cancer. In 2017, doubt was cast about the value of the procedure when studies published in Lancet Oncology concluded that PCI did nothing to improve survival times in people with extensive-stage SCLC, an advanced form of SCLC. Although prophylactic cranial irradiation is still used successfully in people with limited-stage SCLC, its use has dropped off significantly in recent years....